Selank | Anxiolytic Research Peptide
AUD $120
For laboratory research use only. Not for human use.
Research-grade Selank — a synthetic heptapeptide analogue of tuftsin studied in preclinical models for anxiolytic effects, cognitive enhancement, and immune modulation. Third-party HPLC tested to ≥98% purity. For laboratory research use only.
Supply Specifications
| Peptide | Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) |
| Format | Lyophilised powder |
| Purity | ≥98% by HPLC |
| Testing | Third-party HPLC + Mass Spec |
| Storage | -20°C lyophilised |
| Use | Laboratory research use only |
| Price | AUD $120 |
Research Summary
Selank is a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin. It has been studied in preclinical models for its apparent anxiolytic effects, cognitive enhancement, and immune modulation. It is registered as a medication in Russia for anxiety disorders.
Research has examined Selank's apparent interaction with the GABAergic system and its effects on BDNF expression. It is not TGA-approved in Australia and is available for laboratory research use only.
Related Research
Disclaimer: All products supplied by PeptideIQ are for laboratory research use only. They are not approved for human use, consumption, or therapeutic application. PeptideIQ complies with all applicable Australian regulations including the Therapeutic Goods Act 1989.